ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 606698 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 606698; 2) Community: the network communities that were significantly associated with the response to NSC 606698; 3) Molecule: the relationships between components within communities and NSC 606698; 4) MDR: the compounds that were significantly associated with the NSC 606698.

NSC Compound Enrichment Correlation
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.0467178916101838 -0.01770732
NSC 747174 Null 0.0467178916101838 0.26015715
NSC 758664 Sirolimus [USAN] 0.0467178916101838 0.55729299
NSC 96996 B 169 0.0467178916101838 0.12821299
NSC 109451 Null 0.0467178916101842 0.30350192
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0467178916101842 -0.11735315
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0467178916101842 0.18913802
NSC 176503 Fastigilin B 0.0467178916101842 -0.039693438
NSC 274539 Olivomycin D, 3B-O-(2,6-dideoxy-3-C-methyl-L-arabinohexopyranosyl)- 0.0467178916101842 0.23633616
NSC 295501 Camptothecin Derivative 0.0467178916101842 0.1490307
Total:51  Current:45    [First] [Prev] [Next] [Last]